|Zentek Improving lives through nanotechnology. |
Zentek is an IP development and commercialization company that uses expertise in nanomaterials and strategic partnerships to break through the barriers of molecular science and uncover new possibilities in healthcare and beyond. We believe our proven, next-generation, patented nanotechnologies will help solve the world’s most complex challenges.
Next-gen defense to combat transmission and infection.
Our technology helps filter pathogens to reduce the risk of transmission in indoor spaces, higher risk work environments and with social interactions.
Advancing rapid detection and diagnostics.
Our cutting-edge nanotechnology offers fast, affordable, non-invasive, scalable point-of-care detection for numerous pathogens, including viruses like COVID-19, empowering governments, health agencies and individuals worldwide to identify infections and end outbreaks faster than ever before.
Enhancing recovery and health outcomes.
We are developing breakthrough antimicrobial therapies so people can recover faster and live their lives to the fullest. Testing to date has shown our nanotech-powered therapies are safe and effective against numerous pathogens and can potentially transform modalities in medicine across the globe.
In-vitro testing shows 99.9% effectiveness against bacteria, fungi and viruses at extremely low minimum inhibitory concentrations (MIC).
Zentek's patent-pending graphene-based formulation has achieved excellent safety results and has the potential to be a game changer for treating human-contracted pathogens and infectious disease management.
Investor Info: zentek.com